Craniomaxillofacial Implants Market Report and Forecast 2025-2034

The global craniomaxillofacial implants market size was valued at USD 2.30 Billion in 2024, driven by increasing prevalence of facial injuries, trauma, and cranial defects across the globe. The market is expected to grow at a CAGR of 7.13% during the forecast period of 2025-2034, with the values likely to rise from USD 2.5 Billion in 2025 to USD 4.58 Billion by 2034.

Global Craniomaxillofacial Implants Market Overview

Craniomaxillofacial implants are medical devices designed to be used in surgical reconstruction of the skull, jaws, and face. They are commonly made of titanium, owing to its high durability, strength, and biocompatibility. However, with technical advancements, other biocompatible materials have also emerged in the market.

The craniomaxillofacial implants market demand is driven by the rising incidence of oral and oropharyngeal cancer where it is used to reconstruct affected bones and tissues after the surgical removal of tumours. In 2023, around 54,540 adults (39,290 men and 15,250 women) were expected to get diagnosed with oral and oropharyngeal cancers, making it the eighth most common cancer among men.

In addition, craniomaxillofacial implants are often applied in reconstructing facial fractures and injuries resulting from trauma such as accidents, assaults or falls. People born with congenital facial anomalies also undergo craniomaxillofacial surgery. The market is further driven by the rising focus on improving facial aesthetics, prevalence for minimally invasive techniques and the emphasis on manufacturing patient specific implants.

Rising Adoption of 3D Printing Facilities to Boost Craniomaxillofacial Implants Market Growth

In August 2023, Materialise, a 3D printing leader in personalised medical solutions, opened a new 3D printing facility to offer accurate and time saving surgical outcomes during surgery. The new facility in Michigan, United States, specialises in 3D printing of personalized titanium cranio-maxillofacial (CMF) implants, used for facial reconstructive surgeries. Such solutions are designed to facilitate surgeons with more accurate surgical outcomes and offer personalised care at a reasonable cost. This also indicates a rising trend of minimally invasive surgeries, aimed to minimize scarring, and accelerate recovery times for patients.

New Product Launches to Offer Improved Solutions to Patients

Craniomaxillofacial implants can be implanted in the body permanently or temporarily, and they can be withdrawn when no longer required. However, there has been significant emphasis using biomaterial to offer improved patient outcomes. The craniomaxillofacial implants market size is poised to grow with the advent of several new product launches. The Inion CPS™ and Inion CPS™ Baby Bioabsorbable Fixation System are some of the most recent bioabsorbable products containing a range of resorbable meshes, screws and plates in various sizes and shapes. Composed of natural compounds like L-lactic acid, glycolic acid, and trimethylene carbonate, the range of products is safer for clinical use as well. It is one of the few bioabsorbable alternatives comparable to the titanium in its scope of use.

Increasing Technical Advancements to Minimise the Risk of Infection

The craniomaxillofacial implants market value is driven by the increasing research into preventing medical device associated infections. The sudden outbreak of COVID-19 propelled the adoption of new technologies in order to minimize medical device associated infections. In October 2023, Zimmer Biomet and Bactiguard showcased their latest collaboration, a technology designed to reduce the risk of biofilm formation on the medical implants involved in craniomaxillofacial and thoracic applications. The new technology is based on galvanic effects created on the basis of fluid and an ultra-thin noble metal coating amalgamation which inhibits the risk of microbe adherence on the surface.

Global Craniomaxillofacial Implants Market Segmentation

“Craniomaxillofacial Implants Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:

Market Breakup by Type

• Mid Face
• Plates
• Screws
• Mandibular Orthognathic Implants
• Neuro
• Mesh
• Bone Graft
• Dural Repair
• Others

Market Breakup by Material of Construction

• Calcium Phosphate Ceramics
• Titanium
• Alloys and Other Metals
• Polymers or Biomaterials
• Others

Market Breakup by Property

• Resorbable
• Non-Resorbable

Market Breakup by Application Site

• Internal Fixators
• External Fixators

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Global Craniomaxillofacial Implants Market Regional Analysis

North America is anticipated to lead the global market, owing to the considerable rise in craniomaxillofacial surgeries in the United States, increasing healthcare expenditure, and growing sports injuries and injuries related to cranial and facial bones. The growth in this region can be attributed to the increasing number of road accident cases and resultant injuries, trauma cases, the growing number of hospitals, and the rising number of new-borns with facial deformities. Also, various government initiatives, such as establishing the American Society of Craniofacial Surgery (ASCFS) for creating awareness about CMF surgeries and their associated advantages, are likely to contribute significantly to the rising craniomaxillofacial implants market share of the region.

Europe is another significant market owing to its robust healthcare infrastructure and the presence of prominent academic and research institutions. To offer better solutions and address unmet needs of patients, the government and authorities aim at educating the healthcare staff with latest technical advancements in the medical domain. In February 2023, an Indo-German workshop, BIODENT, was organised to foster innovation in design and manufacturing of biomaterials and implants for dental, cranio-maxillofacial reconstruction, and bone regeneration. Such initiatives play a critical role in boosting the craniomaxillofacial implants market growth in the region.

The Asia Pacific region, on the other hand, is expected to witness the highest demand during the forecast period. The demand is likely to emerge due to the high prevalence of hereditary facial abnormalities, a large base of geriatric population, rising awareness of the use of dental and orthopaedic implants and improving healthcare infrastructure. The rising rate of road accidents per year in Asian countries is also projected to increase the demand for craniomaxillofacial implants.

Global Craniomaxillofacial Implants Market: Competitor Landscape

In December 2023, Stryker announced their motive to acquire Serf SAS and executed a binding offer to Serf's corporate parent Menix which market dental implants and equipment for craniomaxillofacial surgery. With this acquisition, the company aims at expanding their product portfolio and offer improved and customised solutions to the patients. The deal is expected to close in first quarter of 2024. The market has been witnessing multiple strategic mergers and acquisitions between prominent companies to enhance their distribution networks and tap into emerging markets.

The key features of the craniomaxillofacial implants market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Zimmer Biomet
• Stryker
• Medartis AG
• KLS Martin Group
• Depuy Synthes
• Osteomed
• Integra Life Sciences Corporation
• Medtronic
• Calavera Surgical Design
• B. Braun Melsungen AG
• General Implants GmbH
• Rebstock Instruments GmbH
• BIOPORE Surgical Implants
• Poriferous
• Osteotec
• Johnson & Johnson Services, Inc.
• Anatomics Pty. Ltd.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

This product will be delivered within 3-5 business days.